Key Highlights

• Net sales increased 37.8% year-over-year to $27.1 million in Q3 2026, with sequential growth of 5.7%

• Adjusted EBITDA surged 155.8% to $3.5 million, with Margin expanding 598 basis points to 13.0%

• Net Income reached $1.4 million, or $0.15 per diluted share, compared to a net loss of $0.1 million in Q3 2025

• Trailing twelve-month Revenue reached a post-COVID record of $91.0 million across the Chemicals segment

Ascent Industries Co(NASDAQ:ACNT), a specialty chemicals platform delivering differentiated, performance-driven chemical solutions, reported its financial results for the third quarter ended September 30, 2026. The company posted net sales of $27.1 million, a 37.8% increase from $19.7 million in the year-ago quarter, driven by both organic growth and the contribution from its Midwest acquisition.

Revenue Growth and Acquisition Contribution

The 37.8% year-over-year revenue increase reflected both organic gains and the impact of the Midwest Graphic Sales and Sigma Coatings acquisition, which closed on May 4, 2026. The Midwest businesses contributed $2.3 million in net sales during Q3 2026, accounting for a portion of the overall growth. On a sequential basis, net sales increased 5.7% from Q2 2026, indicating continued momentum in the underlying business.

For the Trailing Twelve Months ended September 30, 2026, the company achieved post-COVID record net sales of $91.0 million across its Chemicals operations, demonstrating the growth trajectory that management has been building through both organic initiatives and acquisitions.

Profitability and Margin Expansion

The revenue growth translated into meaningful profitability improvement. Gross Profit increased 21.9% to $7.1 million, though gross margin compressed 342 basis points to 26.2% from 29.7%, partially reflecting the integration of the Midwest operations. The Midwest acquisition contributed a net loss of $0.7 million and negative adjusted EBITDA of $0.2 million during the quarter, indicating that the acquired businesses are still in the process of being integrated and optimized.

Despite the gross margin compression, adjusted EBITDA surged 155.8% to $3.5 million, with the adjusted EBITDA margin expanding 598 basis points to 13.0% from 7.0% in Q3 2025. This reflects improved Operating Leverage across the legacy Ascent business, even as the Midwest integration weighs on the blended margin. On a trailing twelve-month basis, the company achieved post-COVID record adjusted EBITDA of $2.9 million across continuing operations.

Net income swung to $1.4 million, or $0.15 per diluted share, compared to a net loss of $0.1 million, or a loss of $0.01 per share, in the prior-year quarter.

Sequential Improvement and Operating Momentum

President and CEO J. Bryan Kitchen highlighted the sequential improvement as evidence of the company's progress. From Q2 to Q3 2026, net sales increased 5.7%, gross profit climbed 28.3%, and adjusted EBITDA improved by approximately $2.1 million. This sequential acceleration suggests that the company's specialty chemicals platform is gaining operational traction even in what management described as muted market conditions.

The company operates as a specialty chemicals platform, delivering differentiated, performance-driven chemical solutions across multiple end markets. The acquisition of Midwest expanded Ascent's capabilities into graphic arts and coating applications, broadening its product portfolio and customer base.

Strategic Direction and Integration

Management indicated that the company is working to grow through what it described as the current market environment, leveraging its expanded portfolio of specialty chemical solutions. The Midwest integration is progressing, and the expectation is that the acquired businesses will move toward profitability as integration activities are completed and operational improvements are implemented.

The company's strategy centers on building a diversified specialty chemicals platform through a combination of organic growth and disciplined acquisitions. Each acquisition is evaluated for its potential to add differentiated chemical solutions, expand end-market exposure, and leverage Ascent's existing Manufacturing and distribution capabilities.

The Bigger Picture

Ascent Industries' Q3 2026 results reflect a company in transition — scaling its specialty chemicals platform while integrating acquisitions and navigating a mixed Demand environment. The 38% revenue growth, record trailing twelve-month sales, and improving EBITDA trajectory indicate forward progress, while the Midwest integration remains a near-term variable. The sequential acceleration in profitability from Q2 to Q3 provides a positive signal heading into the fourth quarter.